Lana Pine

In the ninth episode, Nicholas and Lana unpack several longevity launches making waves, and why regulatory clearance, novelty, and clinical data are 3 separate things brands shouldn't blur together.

In the eighth episode, Nicholas Saraceno examines how social media has reshaped where people get their health and supplement information, from AI-generated "wellness experts" running fabricated ads to registered dietitians and physicians building their own followings to counter it.

In the seventh episode, Nicholas Saraceno traces how ingredients like ashwagandha, fenugreek, and shatavari moved from traditional medicine systems into mainstream supplement formulations, and why the same adaptogen category now driving double-digit market growth is also facing new scrutiny over sourcing and raw material standards.

In the sixth episode, Nicholas Saraceno breaks down why collagen, skin microbiome science, and nutricosmetics are converging into one of the fastest-growing categories in the industry, and why claims substantiation remains the biggest gap between where the science is and where the marketing tends to go.

In the fifth episode, Nicholas Saraceno walks through why natural colors, upcycled ingredients, and sustainable sourcing have become inseparable from consumer trust, and what that shift means for manufacturers deciding where to invest first.

In the fourth episode, Nicholas Saraceno unpacks why negative media coverage of omega-3 research doesn't always tell the full story, and what finished product manufacturers and consumers alike should understand about reading past a headline to the actual study design.

In the third episode, Nicholas Saraceno discusses why male hair thinning is increasingly being understood as a multifactorial, systemic health issue rather than a purely cosmetic one, and what that shift means for how the supplement industry formulates and substantiates products for men.

In the latest episode, Nicholas Saraceno discusses emerging evidence linking premature menopause to cardiovascular risk, while exploring why experts are calling for more targeted clinical research in menopause-focused nutrition products.

In the debut episode, Nicholas Saraceno discusses emerging research on histamine intolerance, including the microbiome’s potential role, limitations surrounding DAO testing, and why diagnosis remains controversial.